Gene expression profiling in stroke: relevance of blood-brain interaction.

Abstract:

:Biomarker profiling is utilized to identify diagnostic and prognostic candidates for stroke. Clinical and preclinical biomarker data suggest altered circulating immune responses may illuminate the mechanisms of stroke recovery. However, the relationship between peripheral blood biomarker profile(s) and brain profiles following stroke remains elusive. Data show that neutrophil lymphocyte ratio (NLR) predicts stroke outcome. Neutrophils release Arginase 1 (ARG1) resulting in T lymphocyte suppression in peripheral blood. Interestingly, the cellular response to stroke may have implications for known biomarker profiles. Conversely, preclinical evidence suggests that upregulation of ARG1 in microglia is a marker of M2 macrophages and may influence neuroprotection. Comparing clinical and preclinical studies creates opportunities to explore the molecular mechanisms of blood and brain biomarker interactions in stroke.

journal_name

Curr Opin Pharmacol

authors

Asano S,Chantler PD,Barr TL

doi

10.1016/j.coph.2015.10.004

subject

Has Abstract

pub_date

2016-02-01 00:00:00

pages

80-6

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(15)00121-6

journal_volume

26

pub_type

杂志文章,评审
  • Psychological side effects of immune therapies: symptoms and pathomechanism.

    abstract::Immunotherapies revolutionised the treatment of several disorders but show specific side-effect profiles which frequently involve psychological symptoms. Long term interferon-alpha (IFN-alpha) therapy can cause wide-ranging psychiatric side-effects from fatigue, insomnia, anxiety to full-blown depression. This treatme...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.06.008

    authors: Kovacs D,Kovacs P,Eszlari N,Gonda X,Juhasz G

    更新日期:2016-08-01 00:00:00

  • Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

    abstract::In most situations, the angiotensin AT2-receptor (AT2R) mediates physiological actions opposing those mediated by the AT1-receptor (AT1R), including a vasorelaxant effect. Nevertheless, experimental evidence vastly supports that systemic application of AT2R-agonists is blood pressure neutral. However, stimulation of A...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.01.004

    authors: Sumners C,de Kloet AD,Krause EG,Unger T,Steckelings UM

    更新日期:2015-04-01 00:00:00

  • In search of new targets for retinal neuroprotection: is there a role for autophagy?

    abstract::Autophagy is a highly conserved catabolic pathway in which proteins and organelles are engulfed by vacuoles that are targeted to lysosomes for degradation. Defects in the autophagic machinery have been described in several neurodegenerative diseases uncovering the tight dependency of neuronal survival on the efficienc...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.09.004

    authors: Russo R,Berliocchi L,Adornetto A,Amantea D,Nucci C,Tassorelli C,Morrone LA,Bagetta G,Corasaniti MT

    更新日期:2013-02-01 00:00:00

  • Drugs acting on SUR1 to treat CNS ischemia and trauma.

    abstract::Sulfonylurea receptor 1 (SUR1) is a molecule with more diverse and critically important functions than previously recognized. Long viewed simply as a subunit involved in formation of a subset of K(ATP) channels, accumulating evidence indicates that SUR1 is newly upregulated in CNS ischemia and injury and is surprising...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2007.10.004

    authors: Simard JM,Woo SK,Bhatta S,Gerzanich V

    更新日期:2008-02-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.

    abstract::Hepatocellular carcinoma (HCC) is the 5th most common cancer, but the 3rd leading cause of cancer death globally with approximately 700,000 fatalities annually. The severity of this cancer arises from its difficulty to detect and treat. The major etiologies of HCC are liver fibrosis or cirrhosis from chronic viral inf...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.04.002

    authors: Black AP,Mehta AS

    更新日期:2018-08-01 00:00:00

  • The case for a role for adenosine in asthma: almost convincing?

    abstract::Mice rendered adenosine deaminase-deficient manifest an 'asthma' phenotype in the lungs that includes mast cell degranulation, eosinophilia, mucus hypersecretion and bronchial hyperresponsiveness. These changes can be reversed by enzyme therapy with adenosine deaminase, and attenuated by theophylline. Theophylline als...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00039-0

    authors: Fozard JR

    更新日期:2003-06-01 00:00:00

  • Oxidative stress-elicited myocardial apoptosis during reperfusion.

    abstract::Myocardial apoptosis primarily triggered during reperfusion has been associated with cardiac dysfunction and extension of infarction. Although potential signaling pathways involved in triggering apoptosis remain to be clearly defined, an increasing number of experiments have implicated the generation of reactive oxyge...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.010

    authors: Zhao ZQ

    更新日期:2004-04-01 00:00:00

  • TNF-alpha in asthma.

    abstract::Although only 5-10% of patients with asthma are relatively unresponsive to treatment with inhaled corticosteroids, refractory asthma represents an important condition, as these patients suffer considerable morbidity and mortality and consume a disproportionately large amount of health resource. Treatment options are l...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.03.001

    authors: Berry M,Brightling C,Pavord I,Wardlaw A

    更新日期:2007-06-01 00:00:00

  • Airway nerves: in vivo electrophysiology.

    abstract::Information about the activity of airway sensory afferent nerves in vivo can be obtained electrophysiologically by extracellular recording of action potentials. Apart from data capture, the basic techniques used for recording sensory nerve activity have not advanced greatly in 50 years. However, clearly they continue ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00153-4

    authors: Adcock JJ

    更新日期:2002-06-01 00:00:00

  • From purified GPCRs to drug discovery: the promise of protein-based methodologies.

    abstract::G-protein-coupled receptors (GPCRs), the largest family of membrane proteins, represent ideal therapeutic targets for a number of disorders and diseases. Besides cell-based assays and high throughput screening (HTS), and thanks to the availability of milligram quantities of active purified receptors, protein-based app...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.04.002

    authors: Alkhalfioui F,Magnin T,Wagner R

    更新日期:2009-10-01 00:00:00

  • 5-HT and the immune system.

    abstract::The classical neurotransmitter, serotonin (5-HT), plays an important role outside of the central nervous system in immune signaling. Here I review recent studies describing 5-HT uptake in dendritic cells and B lymphocytes, 5-HT synthesis in T lymphocytes, and the role of specific 5-HT receptor subtypes in innate and a...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.02.004

    authors: Ahern GP

    更新日期:2011-02-01 00:00:00

  • Opioid-receptor-heteromer-specific trafficking and pharmacology.

    abstract::Homomerization and heteromerization of 7 transmembrane spanning (7TM)/G-protein-coupled receptors (GPCRs) have been an important field of study. Whereas initial studies were performed in artificial cell systems, recent publications are shifting the focus to the in vivo relevance of heteromerization. This is especially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.007

    authors: van Rijn RM,Whistler JL,Waldhoer M

    更新日期:2010-02-01 00:00:00

  • Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.

    abstract::Light offers unique advantages for studying and manipulating biomolecules and the cellular processes that they control. Optical control of ionotropic and metabotropic glutamate receptors has garnered significant interest, since these receptors are central to signaling at neuronal synapses and only optical approaches p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.12.008

    authors: Reiner A,Levitz J,Isacoff EY

    更新日期:2015-02-01 00:00:00

  • Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.

    abstract::In spite of the recent advancement in the molecular characterization of malignant gliomas and medulloblastomas, the treatment of primary brain tumors remains suboptimal. The use of small molecule inhibitors of intracellular signaling pathways, inhibitors of angiogenesis, and immunotherapic agents is limited by systemi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.02.005

    authors: Iacovelli L,Orlando R,Rossi A,Spinsanti P,Melchiorri D,Nicoletti F

    更新日期:2018-02-01 00:00:00

  • Cancer gene therapy with T cell receptors and chimeric antigen receptors.

    abstract::Viral and non-viral gene transfer technologies have been used to efficiently generate therapeutic T cells with desired cancer-specificity. Chimeric antigen receptors (CARs) redirect T cell specificity toward antibody-recognized antigens expressed on the surface of cancer cells, while T cell receptors (TCRs) extend the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.08.006

    authors: Stauss HJ,Morris EC,Abken H

    更新日期:2015-10-01 00:00:00

  • Retrieving GPCR data from public databases.

    abstract::Improvements in databases have already impacted GPCR research. The purpose of the review is to give a snapshot of the GPCR data available and provide utility examples. Consequently, this review covers a small set of major databases, including UniProt for proteins, Ensembl for genes, ChEMBL for bioactive chemistry and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.07.002

    authors: Southan C

    更新日期:2016-10-01 00:00:00

  • Small molecule drugs - optimizing DNA damaging agent-based therapeutics.

    abstract::DNA-targeted chemotherapies remain fundamental in clinical management of both common solid tumours and hematologic malignancies. Recent studies indicate that novel combinations of cytotoxic chemotherapy may have significant activity even in tumours regarded as being resistant to conventional chemotherapy. In addition,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.03.008

    authors: Hartley JA,Hochhauser D

    更新日期:2012-08-01 00:00:00

  • Pharmacodynamic implications for use of antifungal agents.

    abstract::In the last decade, the relationship between drug dosing and treatment efficacy for life-threatening fungal infections has been clarified by application of pharmacodynamic principles to the study of antifungal agents. Similar to antibacterials, antifungal agents can display static or cidal patterns of activity against...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.05.004

    authors: Lewis RE

    更新日期:2007-10-01 00:00:00

  • The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention.

    abstract::Neurodegenerative diseases represent a large group of neurological disorders with heterogeneous clinical and pathological profiles. The majority of current therapeutic strategies provide temporary symptomatic relief but do not target the underlying disease pathobiology and thus do not affect disease progression. G pro...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.02.001

    authors: Huang Y,Todd N,Thathiah A

    更新日期:2017-02-01 00:00:00

  • Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management.

    abstract::Heart disease is the most common cause of death in patients with chronic kidney disease (CKD), particularly in those receiving dialysis. Atherosclerosic cardiovascular (CV) disease (CVD) accounts for a large number of these deaths. Atherosclerosis is accelerated in patients with CKD due predominantly to the high preva...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.12.001

    authors: Balla S,Nusair MB,Alpert MA

    更新日期:2013-04-01 00:00:00

  • Clinical pharmacokinetic-pharmacodynamic analyses: a critical element for developing antibacterial agents.

    abstract::In the current of era of developing antibacterial agents, including those for unmet medical need, Sponsors are required to submit a robust pre-clinical pharmacokinetic-pharmacodynamic (PK-PD) data package in exchange for limited clinical data. However, the clinical data package also needs to be as robust as possible. ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.010

    authors: Bhavnani SM,Hammel JP

    更新日期:2017-10-01 00:00:00

  • Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease.

    abstract::Metabotropic glutamate receptors (mGluRs) are heavily expressed throughout the basal ganglia (BG), where they modulate neuronal excitability, transmitter release and long term synaptic plasticity. Therefore, targeting specific mGluR subtypes by means of selective drugs could be a possible strategy for restoring normal...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.03.004

    authors: Masilamoni GJ,Smith Y

    更新日期:2018-02-01 00:00:00

  • Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.

    abstract::The metabolic syndrome constitutes a group of metabolic conditions that increase the risk of developing diseases, including cardiovascular disease (CVD) and type 2 diabetes (T2D). LXRα/β are regulators of lipogenesis, cholesterol/glucose homoeostasis and inflammatory pathways, processes that are intertwined with devel...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.07.003

    authors: Faulds MH,Zhao C,Dahlman-Wright K

    更新日期:2010-12-01 00:00:00

  • Clinical effectiveness of novel rosacea therapies.

    abstract::Rosacea is a common inflammatory skin disease that is difficult to manage because of the unknown etiology and due to its variable manifestations. These facts and the few new available treatment options make it difficult to select a really effective treatment. This review aims to assess the efficacy and safety of novel...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.12.001

    authors: Feaster B,Cline A,Feldman SR,Taylor S

    更新日期:2019-06-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Understanding the pharmacology of stroke and multiple sclerosis through imaging.

    abstract::Stroke and multiple sclerosis (MS) illustrate how clinical imaging can facilitate early phase drug development and most effective medicine use in the clinic. Imaging has enhanced understanding of the dynamics of evolution of disease pathophysiology, better defining treatment targets. Imaging measures can enable strati...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.10.006

    authors: Matthews PM,Geraghty OC

    更新日期:2014-02-01 00:00:00

  • New pathways to control inflammatory responses in adipose tissue.

    abstract::Obesity is characterized by the presence of chronic inflammation in adipose tissue, particularly in the visceral compartment, that has been causally linked to development of obesity-associated comorbidities. This link can be either direct or indirect, through induction of insulin resistance. This review summarizes rec...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.04.008

    authors: Akasheh RT,Pang J,York JM,Fantuzzi G

    更新日期:2013-08-01 00:00:00

  • In silico models in drug development: where we are.

    abstract::The use and utility of computational models in drug development has significantly grown in the last decades, fostered by the availability of high throughput datasets and new data analysis strategies. These in silico approaches are demonstrating their ability to generate reliable predictions as well as new knowledge on...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.08.007

    authors: Piñero J,Furlong LI,Sanz F

    更新日期:2018-10-01 00:00:00

  • 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.

    abstract::11beta-hydroxysteroid dehydrogenases (11beta-HSDs) catalyse the interconversion of active cortisol and inert cortisone. Two isozymes have been discovered, each with unique properties and powerful biological roles. 11beta-HSD2 potently inactivates cortisol, protecting key tissues. By contrast, 11beta-HSD1 regenerates c...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.09.001

    authors: Seckl JR

    更新日期:2004-12-01 00:00:00